Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.

(2014) D Shyangdan et al.   HEALTH TECHNOLOGY ASSESSMENT

Ethnic Differences in the Relationship Between Insulin Sensitivity and Insulin Response: A systematic review and meta-analysis

(2013) K. Kodama et al.   DIABETES CARE

The Gly(972)Arg Variant of Human IRS1 Gene Is Associated With Variation in Glomerular Filtration Rate Likely Through Impaired Insulin Receptor Signaling

(2012) F. Thameem et al.   DIABETES

Ala/Ala Genotype of Pro12Ala Polymorphism in the Peroxisome Proliferator-Activated Receptor-γ2 Gene Is Associated with Obesity and Insulin Resistance in Asian Indians

(2012) Surya Prakash Bhatt et al.   Diabetes Technology & Therapeutics

The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

(2012) Naga Chalasani et al.   HEPATOLOGY

Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study

(2012) Yuichiro Eguchi et al.   JOURNAL OF GASTROENTEROLOGY

Genetic Polymorphisms of the Human PNPLA3 Gene Are Strongly Associated with Severity of Non-Alcoholic Fatty Liver Disease in Japanese

(2012) Takahisa Kawaguchi et al.   PLoS One

The Association of the Triglyceride-to-HDL Cholesterol Ratio with Insulin Resistance in White European and South Asian Men and Women

(2012) Samiul A. Mostafa et al.   PLoS One

Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease

(2011) A. Baranova et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

(2011) G. Vernon et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Meta-analysis: pioglitazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis

(2011) E. Boettcher et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease

(2011) Kikuko Hotta et al.   BMC Medical Genetics

Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States

(2011) Michael R. Charlton et al.   GASTROENTEROLOGY

Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo-controlled trial

(2011) Claudia O. Zein et al.   HEPATOLOGY

Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta-analysis

(2011) Ruben Hernaez et al.   HEPATOLOGY

Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents

(2011) Joel E. Lavine   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy

(2011) Naoki Tanaka et al.   JOURNAL OF GASTROENTEROLOGY

Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey

(2011) Katsutoshi Tokushige et al.   JOURNAL OF GASTROENTEROLOGY

The role of thiazolidinediones in non-alcoholic steatohepatitis – A systematic review and meta analysis

(2011) Suzanne E. Mahady et al.   JOURNAL OF HEPATOLOGY

Systematic review on the treatment of pentoxifylline in patients with non-alcoholic fatty liver disease

(2011) Wenjun Li et al.   Lipids in Health and Disease

Treatment with insulin sensitizer metformin improves arterial properties, metabolic parameters, and liver function in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled trial

(2011) Elena Sofer et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

NAFLD Recurrence in Liver Transplant Recipients

(2011) Parul Dureja et al.   TRANSPLANTATION

Paraoxonase-1 activity, malondialdehyde and glutathione peroxidase in non-alcoholic fatty liver disease and the effect of atorvastatin

(2011) Waleed Samy et al.   Arab Journal of Gastroenterology

Meta-analysis: insulin sensitizers for the treatment of non-alcoholic steatohepatitis

(2010) M. O. Rakoski et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Atorvastatin and Antioxidants for the Treatment of Nonalcoholic Fatty Liver Disease: The St Francis Heart Study Randomized Clinical Trial

(2010) Temitope Foster et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

(2010) Giovanni Musso et al.   ANNALS OF MEDICINE

The fatty acid composition of plasma cholesteryl esters and estimated desaturase activities in patients with nonalcoholic fatty liver disease and the effect of long-term ezetimibe therapy on these levels

(2010) Hyohun Park et al.   CLINICA CHIMICA ACTA

Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study

(2010) Christopher D. Williams et al.   GASTROENTEROLOGY

High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial

(2010) Ulrich F. H. Leuschner et al.   HEPATOLOGY

A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease

(2010) Giovanni Musso et al.   HEPATOLOGY

Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis

(2010) Herbert Tilg et al.   HEPATOLOGY

Efficacy of ezetimibe for the treatment of non-alcoholic steatohepatitis: An open-label, pilot study

(2010) Masato Yoneda et al.   HEPATOLOGY RESEARCH

Prospective study of hepatocellular carcinoma in nonalcoholic steatohepatitis in comparison with hepatocellular carcinoma caused by chronic hepatitis C

(2010) Katsutoshi Tokushige et al.   JOURNAL OF GASTROENTEROLOGY

A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease

(2010) Yoshio Sumida et al.   JOURNAL OF GASTROENTEROLOGY

Prevalence, gender, ethnic variations, and prognosis of NASH

(2010) Etsuko Hashimoto et al.   JOURNAL OF GASTROENTEROLOGY

Non-alcoholic fatty liver disease's prevalence and impact on alanine aminotransferase associated with metabolic syndrome in the Chinese

(2010) Xu-hong Hou et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

A position statement on NAFLD/NASH based on the EASL 2009 special conference

(2010) Vlad Ratziu et al.   JOURNAL OF HEPATOLOGY

A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis

(2010) Vlad Ratziu et al.   JOURNAL OF HEPATOLOGY

NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease

(2010) Munechika Enjoji et al.   Lipids in Health and Disease

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

(2010) Arun J. Sanyal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Outcome After Liver Transplantation for NASH Cirrhosis

(2009) S. M. Malik et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Iron Overload Is Associated with Hepatic Oxidative Damage to DNA in Nonalcoholic Steatohepatitis

(2009) N. Fujita et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years

(2009) A E Feldstein et al.   GUT

Advances in pediatric nonalcoholic fatty liver disease

(2009) Rohit Loomba et al.   HEPATOLOGY

Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis

(2009) Kittichai Promrat et al.   HEPATOLOGY

Betaine for nonalcoholic fatty liver disease: Results of a randomized placebo-controlled trial

(2009) Manal F. Abdelmalek et al.   HEPATOLOGY

Decreased survival of subjects with elevated liver function tests during a 28-year follow-up

(2009) Cecilia Söderberg et al.   HEPATOLOGY

Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss

(2009) Nathan A. Johnson et al.   HEPATOLOGY

Etiology of liver cirrhosis in Japan: a nationwide survey

(2009) Kojiro Michitaka et al.   JOURNAL OF GASTROENTEROLOGY

Pharmacological Interventions for Nonalcoholic Fatty Liver Disease in Adults and in Children: A Systematic Review

(2009) Piotr Socha et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease

(2009) Vishal Bhagat et al.   LIVER TRANSPLANTATION

Endocrine and liver interaction: the role of endocrine pathways in NASH

(2009) Paola Loria et al.   Nature Reviews Gastroenterology & Hepatology

Comparison of Weight-Loss Diets with Different Compositions of Fat, Protein, and Carbohydrates

(2009) Frank M. Sacks et al.   NEW ENGLAND JOURNAL OF MEDICINE

A 12-Week Aerobic Exercise Program Reduces Hepatic Fat Accumulation and Insulin Resistance in Obese, Hispanic Adolescents

(2009) Gert-Jan van der Heijden et al.   Obesity

Final results of a long-term, clinical follow-up in fatty liver patients

(2009) Sanne Dam-Larsen et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial

(2009) John Willy Haukeland et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis

(2009) Eugen Florin Georgescu et al.   WORLD JOURNAL OF GASTROENTEROLOGY

The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease

(2008) A. Nar et al.   ACTA DIABETOLOGICA

Effect of Bariatric Surgery on Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis

(2008) Rajasekhara R. Mummadi et al.   Clinical Gastroenterology and Hepatology

Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver

(2008) Nila Rafiq et al.   Clinical Gastroenterology and Hepatology

Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis

(2008) Guruprasad P. Aithal et al.   GASTROENTEROLOGY

Familial Aggregation in Patients with Non-Alcoholic Steatohepatitis

(2008) Katsutoshi Tokushige et al.   INTERNAL MEDICINE

Transient elastography for measurement of liver stiffness measurement can detect early significant hepatic fibrosis in Japanese patients with viral and nonviral liver diseases

(2008) Noriyuki Obara et al.   JOURNAL OF GASTROENTEROLOGY

Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia

(2008) Hideyuki Hyogo et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

(2008) Stefano Romeo et al.   NATURE GENETICS

Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD)

(2007) M. Yoneda et al.   DIGESTIVE AND LIVER DISEASE